
Novanta, Inc. Hits Day High with 8.27% Surge in Strong Intraday Performance
2025-10-27 17:34:05Novanta, Inc. has seen a notable rise in stock performance, gaining 8.27% today and achieving an intraday high of USD 130.97. Over the past week and month, the company has outperformed the S&P 500. However, it has faced a decline over the past year, with a low Debt to EBITDA ratio indicating strong debt servicing capability.
Read MoreIs Novanta, Inc. technically bullish or bearish?
2025-09-20 19:17:46As of 25 August 2025, the technical trend for Novanta, Inc. has changed from mildly bearish to bearish. The MACD is bearish on both the weekly and monthly time frames, and the daily moving averages also indicate a bearish stance. The RSI shows a bullish signal on the monthly but no signal on the weekly, suggesting mixed momentum. Bollinger Bands and KST are both bearish on the weekly and monthly, while Dow Theory indicates a mildly bullish weekly but a mildly bearish monthly outlook. Overall, the technical stance is bearish with moderate strength. In terms of performance, Novanta has underperformed the S&P 500 across multiple periods, with a year-to-date return of -23.27% compared to the S&P's 12.22%, and a one-year return of -30.57% versus the S&P's 17.14%....
Read MoreIs Novanta, Inc. overvalued or undervalued?
2025-09-20 17:52:31As of 7 July 2025, the valuation grade for Novanta, Inc. has moved from fair to very expensive, indicating a significant shift in its valuation outlook. The company is currently overvalued, with a P/E ratio of 61, a Price to Book Value of 5.95, and an EV to EBITDA of 26.72. In comparison, peers such as Cognex Corp. have a P/E of 61.49 and Onto Innovation, Inc. shows a more favorable EV to EBITDA of 13.94, highlighting Novanta's relative overvaluation. Recent performance metrics further underscore this valuation concern, as Novanta's stock has underperformed against the S&P 500, with a year-to-date return of -23.27% compared to the index's 12.22%. Over the past year, the company has seen a decline of 30.57%, while the S&P 500 gained 17.14%, reinforcing the notion that Novanta is not only overvalued but also struggling to deliver returns in a favorable market environment....
Read More





